Chemical Structure (Clonidine 01)
Chemical structure of clonidine showing the chlorinated aromatic ring connected to the imidazoline ring.*
Clonidine
Product Images NDC 51862-454
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 51862-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Clonidine 02)
An illustration diagram showing the layered structure of the Clonidine .3 mg/24h transdermal patch. The labeled layers from top to bottom are Backing, Drug Reservoir, Control Membrane, Adhesive, and Slit Release Liner, detailing the patch's composition.*
Figure 1 (Clonidine 03)
An illustration showing the application of a Clonidine .3 mg/24h transdermal patch by Mayne Pharma Inc. The image highlights the placement of the patch on the upper arm or chest area, along with an adhesive cover to secure the patch if needed.*
Figure 2 (Clonidine 04)
Clonidine Transdermal System USP 0.1 mg/day label showing delivery rate and usage instructions. It notes a 0.1 mg/day in vivo delivery over one week, cautions about removing the patch before MRI procedures, and lists active ingredient and inactive components. The labeler is Mayne Pharma Inc.*
Figure 2 (Clonidine 05)
Clonidine Transdermal System, USP 0.3 mg/24h adhesive patch by Mayne Pharma Inc. The image shows one round, white transdermal patch and its white protective wrapper labeled with product name, contents as 1 adhesive cover, and a warning that the wrapper does not contain active medication and should be applied over the patch if necessary.*
Figure 3 (Clonidine 06)
An instructional diagram showing hands peeling or handling a Clonidine transdermal system label or backing card. The image focuses on the process of removing or applying the transdermal patch, highlighting printed text on the label such as the dosage '.3 mg/24h'.*
Figure 4 (Clonidine 07)
An instructional illustration showing two hands, with one hand peeling back or removing a protective backing from a small adhesive patch, likely demonstrating how to apply a transdermal patch.*
Figure 5 (Clonidine 08)
An illustration showing a person applying a transdermal patch to the upper arm. The patch is rectangular and positioned on the outer upper arm area, demonstrating how to place a medication patch on the skin.*
Figure 6 (Clonidine 09)
Clonidine Transdermal System, USP packaging displaying one adhesive cover and one round patch. The label includes a warning that the adhesive cover does not contain active medication and instructions to apply it over the patch if necessary. The labeler is Mayne Pharma Inc.*
Principal Display Panel (0.1 mg Patch Pouch Carton)
Clonidine Transdermal System USP 0.1 mg/day packaging label from Mayne Pharma Inc. The label states the patch delivers 0.1 mg per day for one week and contains 4 systems with 4 adhesive covers. It includes safety instructions for MRI removal, inactive ingredients, storage conditions, and manufacturing details indicating it is made in Italy.*
Principal Display Panel (0.2 mg Patch Pouch Carton)
Clonidine Transdermal System USP 0.2 mg/day patch packaging label from Mayne Pharma Inc. The label states a programmed in vivo delivery of 0.2 mg per day for one week. The package contains 4 transdermal systems and 4 adhesive covers. The label includes a warning to remove the patch before undergoing MRI and notes the product is for transdermal use only.*
Principal Display Panel (0.3 mg Patch Pouch Carton)
Clonidine Transdermal System USP 0.3 mg/day patch packaged by Mayne Pharma Inc. The carton delivers 0.3 mg of clonidine per day for one week and includes 4 transdermal systems and 4 adhesive covers. It contains warnings about MRI procedures and storage instructions. Manufactured in Italy.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
